Helical Fusion Launches Helix Program “Official Partners” to Build Japan’s Industrial Coalition for Commercial Fusion Energy
28.4.2026 05:00:00 CEST | Business Wire | Press release
Multiple long-established Japanese companies join as inaugural partners in a shared push to build the fusion energy industry; Helical Fusion also completed the first close of its Series B round
Helical Fusion Co., Ltd., a fusion energy company developing a Helical stellarator power plant, today announced the launch of Helix Program Official Partners, a new strategic partnership framework designed to bring together long-term industrial collaborators committed to advancing fusion from laboratory progress to real-world fusion power deployment.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427596284/en/
Helical Fusion’s Integrated Demonstration Device, “Helix HARUKA,” currently under construction (photographed at the company’s dedicated workspace within the National Institute for Fusion Science in Gifu, Japan)
The Helix Program is Helical Fusion’s core initiative to realize commercially viable fusion energy in the 2030s. Rather than starting from a reactor concept alone, the program works backward from the three essential requirements for commercial fusion power: net electricity, continuous operation, and high maintainability. Based on this framework, Helical Fusion has adopted the Helical Stellarator as the reactor approach with the clearest pathway to achieving all three requirements in a fully operational fusion power plant, building on Japan’s decades-long research foundation in helical stellarator technology.
The first three companies to join as founding Official Partners are NICHIAS Corporation, Hasetora Spinning Co., Ltd., and Seno Kisen Co., Ltd. Each brings a business legacy spanning roughly a century or more. More importantly, they are joining not simply as suppliers or investors, but as long-term partners who share Helical Fusion’s ambition of helping build the fusion energy industry itself.
“Commercial fusion will not be realized by a startup alone, or by physics alone,” said Takaya Taguchi, Co-Founder and CEO of Helical Fusion Co., Ltd. “It requires a coalition of companies willing to apply the strengths they have built over generations to one of the most consequential industrial challenges of the next century. Helix Program Official Partners was created for that purpose.”
Unlike a conventional sponsorship program, Helix Program Official Partners is structured for companies that will work alongside Helical Fusion as active industrial collaborators. Participation is tied not only to strategic business alignment, but also to capital commitment. The framework is intended to support manufacturing and construction for Helix HARUKA, Helical Fusion’s Integrated Demonstration Device, and ultimately Helix KANATA, the company’s planned first commercial plant in the 2030s.
About Helix Program Official Partners
NICHIAS Corporation, founded in 1896, has supplied insulation, sealing, and high-performance industrial products to sectors that have underpinned modern industrial society, including shipbuilding, petroleum refining and petrochemicals, electric power, automobiles, construction, and semiconductors. Its participation reflects the view that the technologies required for large-scale industry in one era can become enabling technologies for a new energy system in the next.
Hasetora Spinning Co., Ltd., founded in 1887, has evolved through more than a century of manufacturing while building expertise in materials and textile-based technologies. Its decision to join points to a broader idea central to fusion commercialization: that advanced materials companies with deep manufacturing DNA may have an important role in shaping the infrastructure of future energy.
Seno Kisen Co., Ltd., founded in 1946 and built through decades of global maritime operations, brings expertise in industrial logistics, fleet management, and the movement of essential resources that sustain economies. Its participation underscores that future energy systems will not depend only on invention, but on the operational disciplines needed to move, deploy, and sustain large-scale assets in the real world.
The company is already advancing that roadmap in hardware. Manufacturing and construction are underway for magnet demonstration work for Helix HARUKA at a dedicated Helical Fusion workspace on the campus of the National Institute for Fusion Science in Toki, Gifu.
In connection with this broader push, Helical Fusion also completed the first close of its Series B round, raising approximately JPY 2.7 billion. Investors in the round include NICHIAS Corporation, Hasetora Spinning Co., Ltd., Seno Kisen Co., Ltd., Ecrowd NEXT, Konoike Transport Co., Ltd., and MITANI SANGYO Co., Ltd., among others. Among these investors, NICHIAS Corporation, Hasetora Spinning Co., Ltd., and Seno Kisen Co., Ltd. are also participating as the Helix Program Official Partners. Including grants and loans, the company’s total funding to date has reached approximately JPY 9.8 billion. The company said this additional capital will support continued development under the Helix Program alongside the expansion of its industrial partnership network.
About Helical Fusion Co., Ltd.
Helical Fusion Co., Ltd. is a company working to commercialize fusion energy through the development of the Helical Stellarator. The company was founded in 2021 as a spin-out from the National Institute for Fusion Science (NIFS), leveraging research achievements accumulated at NIFS.
View source version on businesswire.com: https://www.businesswire.com/news/home/20260427596284/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Investor Supporting Japan’s Entertainment Industry, Yoshihiro Shimamura, to Visit France Workshop to be Held During the Cannes Film Festival28.4.2026 04:00:00 CEST | Press release
Shimamura Yoshihiro Film Planning Inc. (Head Office: Osaka, Japan; CEO: Yoshihiro Shimamura), a company engaged in film production and investment, will host a workshop in France during this year’s Cannes Film Festival, as part of its commitment to further advancing the entertainment industry. The company invests in leading entertainment-related businesses in Japan and places strong emphasis on long-term value creation. It identifies the cultural and entertainment sectors as high-growth areas and is actively involved in international co-productions as a core part of its film production activities. As a recent investment, the company acquired 2,000,000 shares of Hankyu Hanshin Holdings, Inc.—a major Japanese entertainment conglomerate known for producing content enjoyed across generations—and became a major shareholder (as of March 25, 2026). Through such investments, the company aims to support the global expansion of Japanese entertainment while exploring synergies with its own interna
Alsym Energy Announces Na-Series Battery Success Developed With Physics-Informed AI Platform27.4.2026 21:25:00 CEST | Press release
Alsym’s proprietary physics-informed AI platform powered the development of its Na-Series batteries—a non-flammable, high performance and low cost energy solution positioned to serve critical energy storage markets including data centers, utilities, telecommunications, commercial real estate, industrial and defense, among others. Alsym Energy, a pioneer in non-flammable, high-performance sodium-ion batteries, today announced details of the proprietary physics-informed AI platform used to develop the company’s recently launched Na-Series sodium-ion batteries. By integrating fundamental physics models with AI, autonomous testing and proprietary molecular diagnostics in a closed-loop system, Alsym is accelerating the design of safer, inexpensive, commercialized batteries through all phases of the development cycle. As global demand for electricity surges, the limitations of lithium-ion batteries have become increasingly apparent, particularly around safety and supply chain constraints. Li
Backed by Investments Exceeding $1 Billion, PCI Pharma Services Announces Major Expansion of US Sterile Fill-Finish and Drug-Device Delivery Combination Capabilities27.4.2026 16:00:00 CEST | Press release
As pharma manufacturers prioritize US supply chain resilience, highlights include high-speed isolator filling lines for prefilled syringes, cartridges and vials, and drug-device combination assembly and packaging. PCI Pharma Services (“PCI”) – a world-leading integrated global contract development and manufacturing organization (CDMO) focused on innovative biologic and small molecule therapies – announced a series of major infrastructure investments that substantially deepen its sterile fill-finish and advanced drug delivery capabilities. As pharma manufacturers and their development partners increasingly prioritize US supply chain resilience, PCI’s latest investments come as part of a broader commitment exceeding $1 billion across the CDMO’s US and European operations, reinforcing its ability to provide seamless support for drug product development and manufacturing, clinical trial supply and drug-device combination assembly from clinical stages through commercial launch – all underpi
Pure Lithium Appoints Renowned Battery Expert Dr. Yuan Gao to Board of Directors27.4.2026 15:53:00 CEST | Press release
Pure Lithium Corporation, a vertically integrated lithium metal battery technology company, is pleased to announce that world-renowned inventor and battery expert Dr. Yuan Gao has joined the company’s Board of Directors. Dr. Gao has been an invaluable member of Pure Lithium’s Scientific Advisory Board since October of 2023. "We are thrilled to have Dr. Gao join our board as we focus on rapidly scaling our technology in the most capital efficient manner possible,” said Pure Lithium Founder, Chairman and CEO Emilie Bodoin. “Dr. Gao is a brilliant scientist who also has deep commercial expertise, a rare combination. He is also unique in the industry because his experience spans the entire battery materials value chain, including all of Pure Lithium’s verticals. His insights over the years have been critical in advancing our technology, and his experience as a director of public companies will strengthen our board.” Dr. Gao commented: “I am thrilled to join the board of Pure Lithium Corpor
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development27.4.2026 15:00:00 CEST | Press release
Phase 1 dose-escalation trial represents the first clinical trial of a product developed using the AraLinQ™ ADC technology and marks Taiho’s expansion into the clinical development of ADCs for oncology Taiho Oncology, Inc., Taiho Pharmaceutical Co., Ltd., and Araris Biotech AG (“Araris”) today announced that the U.S. Food and Drug Administration (FDA) has completed its Investigational New Drug (IND) review period for ARC-02, an antibody-drug conjugate (ADC) being developed for the treatment of non-Hodgkin lymphoma, enabling Taiho Oncology to initiate a Phase 1 dose-escalation clinical trial of ARC-02. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260427127507/en/ Taiho Pharmaceutical acquired Araris Biotech in March 2025, expanding Taiho group’s capabilities in biologics and ADC research and development. Araris is a spin-off of the Paul Scherrer Institute and ETH in Switzerland focused on the development of antibody-drug co
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom